Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma
Clinical trial NCT06793956 · RECRUITING
Trial details
- NCT number
- NCT06793956
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-21
- Primary completion
- 2026-01-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.